LIFCO COMMENCES TRADING ON NASDAQ STOCKHOLM TODAY

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
LIFCO COMMENCES TRADING ON NASDAQ STOCKHOLM TODAY

+---------------------------------------------------------------------------+ |NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR| |INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA | +---------------------------------------------------------------------------+ Lifco AB (publ) (“Lifco” or “the Company”) and its owner Carl Bennet AB (“CBAB” or “the Principal Shareholder”) today announces the outcome of the offering of the Company’s series B shares (the “Offering”) and the listing on Nasdaq Stockholm’s main list. The interest for the Offering has been significant, both among the general public in Sweden and among institutional investors in Sweden and abroad. The Offering was subscribed for more than seven times. The Offering in brief · As previously announced, the price in the Offering is SEK 93 per series B share (“the Offering Price”), corresponding to a market value of all shares issued by Lifco of approximately SEK 8.4 billion. · The Offering originally comprised 34,602,400 existing series B shares in the Company, but has, in accordance with the terms of the Offering, been increased by CBAB with 6,606,700 additional series B shares, entailing that a total of 41,209,100 series B shares, corresponding to approximately 45.4% of the shares and 28.3% of the votes in Lifco, are sold by the Principal Shareholder. · The over-allotment option, which according to the terms of the Offering can be exercised by the Global Coordinator up until and including 19 December 2014, could entail that 4,120,900 additional series B shares are included in the Offering (the “Over-allotment option”).[1] (http://connect.ne.cision.com#_ftn1) · Provided that the Over-allotment option is fully exercised, the Offering will comprise a total of 45,330,000 series B shares, corresponding to approximately 49.9% of the number of shares in Lifco, which means that the total value of the Offering amounts to approximately SEK 4.2 billion. · As a result of the Offering, more than 14,000 new shareholders have holdings in Lifco. · CBAB has the intention of remaining a long-term majority owner in the Company and will, if the Over-allotment option is exercised in full, hold approximately 50.1% of the shares and approximately 68.9% of the votes in the Company. · As previously announced, the Fourth Swedish National Pension Fund (AP4) and Didner & Gerge Fonder have acquired in total 13,626,400 shares in the Offering, on the same terms as the other investors, corresponding to approximately 15.0% of the number of shares in Lifco. · Trading in the Lifco share on Nasdaq Stockholm’s main list commences today, 21 November 2014, with the ticker “LIFCO B”.[2] (http://connect.ne.cision.com#_ftn2) Fredrik Karlsson, CEO of Lifco, comments: “Together with all employees in Lifco, I am very happy about the general public’s as well as investors’ interest and confidence in Lifco. The response from investors has been very positive both in Sweden and abroad and we will continue to work diligently in order to increase profits every day.” Carl Bennet, Chairman of the Board of Directors of Lifco and owner of CBAB, comments: “Lifco is a very strong company with leading industry and trade operations in the group and with strong growth in profits. We are happy about the positive response that the general public and so many investors have expressed over Lifco, including its management team and employees. Lifco has now obtained new long-term and solid owners that will take part in Lifco’s continued growth. At the same time, Carl Bennet AB has achieved a transparent structure with three listed holdings in Lifco, Getinge and Elanders.” Advisors SEB is acting as Sole Global Coordinator and Bookrunner and ABG Sundal Collier and Carnegie are acting as Co-Lead Managers (jointly “Managers”) in connection with the Offering. Vinge and Latham & Watkins are legal advisors to Lifco and Hammarskiöld & Co is legal advisor to the Managers. For further information, please contact: Åse Lindskog Media and Investor Relations Tel +46 730 244 872, ir@lifco.se About Lifco Lifco acquires and develops market leading, niched companies with a potential to deliver sustainable profit growth and good cash flow. The Group has three business areas; Dental, Demolition & Tools and Systems Solutions. Lifco is guided by a clear management philosophy based on the company having a long-term view on its holdings, a focus on profitability and a decentralized organization. Lifco has about 100 companies in 30 countries. The Group had a turnover of more than 6 billion SEK and an EBITA-margin of 11.5% in 2013. Read more at www.lifco.se. Lifco announces this information in accordance with the Securities Market Act and/or the Act on Trading in Financial Instruments. This information was submitted for announcement at 8.00am on 21 November 2014. Important information This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by Lifco AB (publ) (“Lifco” or the "Company") in any jurisdiction where such offer or sale would be unlawful. In any EEA Member State, other than Sweden, that has implemented Directive 2003/71/EC as amended (together with any applicable implementing measures in any member State, the “Prospectus Directive”), this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive. This document and the information contained herein are not for distribution or release, directly or indirectly, in or into the United States of America, Canada, Japan or Australia. This document does not constitute an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Canada, Japan or Australia or in any jurisdiction in which any offer or solicitation would be unlawful. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States absent registration or pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. In the United Kingdom, this document and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” (as defined in section 86(7) of the Financial Services and Markets Act 2000) and who are (i) persons having professional experience in matters relating to investments who fall within the definition of “investment professionals” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). Persons who are not relevant persons should not take any action on the basis of this document and should not act or rely on it. An offering of securities has been made by means of a prospectus that may be obtained from the issuer or selling security holder which contains detailed information about the Company and its management, as well as financial statements. This document is not a prospectus for the purposes of the Prospectus Directive. Investors should not subscribe for any securities referred to in this document except on the basis of information contained in the prospectus. Matters discussed in this release may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe," "expect," "anticipate," "intends," "estimate," "will," "may," "continue," "should" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond the Company’s control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this release speak only as at its date, and are subject to change without notice. ---------------------------------------------------------------------- [1] (http://connect.ne.cision.com#_ftnref1) The Over-allotment option can be exercised, in whole or in part, on one or more occasions, by SEB as responsible for any stabilisation measures. [2] (http://connect.ne.cision.com#_ftnref2) Trading in the Lifco share on Nasdaq Stockholm’s main list is, up to and including 24 November 2014, conditional upon the conditions of the Offering being fulfilled.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 56

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Ideas Abu Dhabi Puts Water Innovation on Stage

Updated Category News Views 158

Water rarely gets the spotlight until a pipe fails, a harvest shrinks, or a city starts rationing. That is why the agenda around Ideas Abu Dhabi at the 2026 UN Water Conference deserves more than the usual polite nod given to conference programming. From 7 to 10 December in Abu Dhabi, this is shaping up as a public-facing attempt to connect a hard physical problem with...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 114

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 114

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Teachers in Space Takes Its Classroom Model Orbital

Updated Category News Views 82

Two teachers strapped into a research flight may sound like a glossy space-age photo op, but the useful part of this plan sits back in the classroom with the students staring at the data. Teachers in Space wants to send two educators aboard a Virgin Galactic research flight expected in 2027, and it is raising $2 million to fund the broader educational program and mission....

Continue Reading
Physiatry or Orthopedics: Sorting Out Pain Care Choices

Updated Category News Views 47

Pain care gets muddled the minute people assume every ache needs the same doorway. Dr. Mala Young, a physical medicine and rehabilitation expert in Ann Arbor, Michigan, makes a useful distinction: a physiatrist and an orthopedic doctor may both see pain, mobility trouble, and injury, but they are not interchangeable. That sounds obvious until someone is staring at back...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 117

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
TGHL Eyes U.S. Battery Shift Through EnChem Merger

Updated Category News Views 220

A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 22

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 177

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading

Top 5 Most Recently Viewed Articles

Impact of Withdrawal on Menthol Cigarette Regulation Efforts

Updated Category News Views 158

The Trump Administration's Recent Decision Recently, the Trump administration made headlines by withdrawing a previously proposed ban on menthol cigarettes in the United States. This decision marks a significant setback for health regulators and activists who have long been advocating for healthier tobacco policies. Background of the Proposal In April 2022, the Food and...

Continue Reading
Carta Healthcare Secures Gold by Innovating Clinical Data

Updated Category News Views 18

Tackling a Stubborn Healthcare Pain Point Let's face it: the healthcare industry's data management game has been sweating buckets over a Herculean task for years. A staggering $10-15 billion gets burned annually thanks to inefficient clinical data abstraction. Today's hero of this tale? Carta Healthcare, which just snagged a shining Gold at the 2026 Stevie Awards in...

Continue Reading
SentinelOne Earns Prestigious Recognition from Gartner for 2024

Updated Category News Views 456

SentinelOne's Recent Achievement in Cloud Security SentinelOne (NYSE: S), a prominent player in the field of AI-driven security solutions, has recently been acknowledged as a Customers' Choice in the 2024 Gartner® Peer Insights™ report specifically for Cloud-Native Application Protection Platforms. This recognition reflects feedback from a broad user base, emphasizing...

Continue Reading
Tingus Goose: A Premium Idle Game Experience on Steam

Updated Category News Views 201

Exciting Announcement for Gamers The cult phenomenon, Tingus Goose, is making its debut on Steam as a fully enhanced 1.0 edition designed for PC players. Co-published by Playsaurus and Ultraplayers, this adaptation aims to deliver the ultimate idle gaming experience, free from the distractions found in mobile versions. What’s New in Tingus Goose? Unique Gameplay...

Continue Reading
TrackerRMS Launches Innovative Onboarding+ Solution for Staffing

Updated Category News Views 368

Introducing the New Onboarding+ Solution by TrackerRMS TrackerRMS has taken a significant step in revolutionizing the recruitment landscape with the introduction of its Onboarding+ solution. This innovative tool is designed specifically for recruitment agencies looking to enhance their onboarding process and improve the overall candidate journey. By integrating advanced...

Continue Reading